Literature DB >> 26018405

Classic thrombophilic gene variants.

Pier Mannuccio Mannucci1, Massimo Franchini.   

Abstract

Thrombophilia is defined as a condition predisposing to the development of venous thromboembolism (VTE) on the basis of a hypercoagulable state. Over the past decades, great advances in the pathogenesis of VTE have been made and nowadays it is well established that a thrombophilic state may be associated with acquired and/or inherited factors. The rare loss-of-function mutations of the genes encoding natural anticoagulant proteins (i. e. protein C, protein S and antithrombin) and the more common gain-of-function polymorphisms factor V Leiden and prothrombin G20210A are the main genetic determinants of thrombophilia. In addition, non-O blood group has been consistently demonstrated to be the most frequent inherited marker of an increased risk of VTE. The mechanism role of these inherited thrombophilia markers will be discussed in this narrative review.

Entities:  

Keywords:  ABO blood group; Inherited thrombophilia; factor V Leiden; natural anticoagulants; prothrombin mutation

Mesh:

Substances:

Year:  2015        PMID: 26018405     DOI: 10.1160/TH15-02-0141

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  17 in total

1.  α2-Macroglobulin Is a Significant In Vivo Inhibitor of Activated Protein C and Low APC:α2M Levels Are Associated with Venous Thromboembolism.

Authors:  Laura Martos; Luis Andrés Ramón; Julia Oto; Álvaro Fernández-Pardo; Santiago Bonanad; Ana Rosa Cid; Andras Gruber; John H Griffin; Francisco España; Silvia Navarro; Pilar Medina
Journal:  Thromb Haemost       Date:  2018-02-15       Impact factor: 5.249

2.  High prevalence of congenital thrombophilia in patients with pregnancy-related or idiopathic venous thromboembolism/pulmonary embolism.

Authors:  Makoto Ikejiri; Hideo Wada; Norikazu Yamada; Maki Nakamura; Naoki Fujimoto; Kaname Nakatani; Akimasa Matsuda; Yosihito Ogihara; Takeshi Matsumoto; Yuki Kamimoto; Tomoaki Ikeda; Naoyuki Katayama; Masaaki Ito
Journal:  Int J Hematol       Date:  2016-10-20       Impact factor: 2.490

3.  Spontaneously developed paraplegia in a patient with Factor V Leiden mutation.

Authors:  Ismail Boyraz; Bunyamin Koc; Sirzat Cogalgil
Journal:  Spinal Cord Ser Cases       Date:  2016-04-07

4.  Prothrombotic genetic risk factors in patients with very early ST-segment elevation myocardial infarction.

Authors:  Loukianos S Rallidis; Argyri Gialeraki; Georgios Tsirebolos; Stylianos Tsalavoutas; Maria Rallidi; Efstathios Iliodromitis
Journal:  J Thromb Thrombolysis       Date:  2017-08       Impact factor: 2.300

5.  Venous thromboembolism does not share familial susceptibility with retinal vascular occlusion or glaucoma: a nationwide family study.

Authors:  Bengt Zöller; Xinjun Li; Jan Sundquist; Kristina Sundquist
Journal:  J Thromb Thrombolysis       Date:  2016-11       Impact factor: 2.300

Review 6.  Prothrombotic Fibrin Clot Phenotype in Patients with Deep Vein Thrombosis and Pulmonary Embolism: A New Risk Factor for Recurrence.

Authors:  Anetta Undas
Journal:  Biomed Res Int       Date:  2017-06-27       Impact factor: 3.411

7.  Family history of venous thromboembolism and mortality after venous thromboembolism: a Swedish population-based cohort study.

Authors:  Bengt Zöller; Mirnabi Pirouzifard; Jan Sundquist; Kristina Sundquist
Journal:  J Thromb Thrombolysis       Date:  2017-05       Impact factor: 2.300

8.  Classic Thrombophilias and Thrombotic Risk Among Middle-Aged and Older Adults: A Population-Based Cohort Study.

Authors:  Eric Manderstedt; Christina Lind-Halldén; Christer Halldén; Johan Elf; Peter J Svensson; Björn Dahlbäck; Gunnar Engström; Olle Melander; Aris Baras; Luca A Lotta; Bengt Zöller
Journal:  J Am Heart Assoc       Date:  2022-02-03       Impact factor: 6.106

9.  High Risk of Venous Thromboembolism in Klinefelter Syndrome.

Authors:  Bengt Zöller; Jianguang Ji; Jan Sundquist; Kristina Sundquist
Journal:  J Am Heart Assoc       Date:  2016-05-20       Impact factor: 5.501

10.  Deficiencies of the Natural Anticoagulants - Novel Clinical Laboratory Aspects of Thrombophilia Testing.

Authors:  Zsuzsanna Bereczky; Réka Gindele; Marianna Speker; Judit Kállai
Journal:  EJIFCC       Date:  2016-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.